Enteris BioPharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 22
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2
  • Investments
  • 1

Enteris BioPharma General Information

Description

Developer of oral dosage formulations for peptides and small molecule therapeutics. The company's internal product pipeline of oral tablet reformulations of drug products address significant treatment opportunities for which there is no oral delivery option, improving the permeability and bioavailability of BCS III and BCS IV small molecules.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 83 Fulton Street
  • Boonton, NJ 07005
  • United States
+1 (973) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enteris BioPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enteris BioPharma‘s full profile, request access.

Request a free trial

Enteris BioPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of oral dosage formulations for peptides and small molecule therapeutics. The company's internal product pipel
Drug Discovery
Boonton, NJ
22 As of 2021
00.00 0000-00-00
000000000000

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
0000 000000000
Carmiel, Israel
000 As of 0000
000.00
000000000 000.00

0000 000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
000000000000000
Newton, MA
00 As of 0000
0000
000000 - 000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enteris BioPharma Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Protalix Biotherapeutics Formerly VC-backed Carmiel, Israel 000 000.00 000000000 000.00
0000 000000000000 Formerly VC-backed Newton, MA 00 0000 000000 - 000 0000
000000 00000000000 Venture Capital-Backed New York, NY 000.00 00000000000 000.00
00000000 Formerly VC-backed Rockville, MD 0 000.00 00000000 000.00
0000000 0000000000 Formerly VC-backed Watertown, MA 00 00000 000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Enteris BioPharma Executive Team (6)

Name Title Board Seat Contact Info
Rajiv Khosla Ph.D Chief Executive Officer
Paul Shields Chief Operating Officer
Gary Shangold MD Chief Medical Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Enteris BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enteris BioPharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Enteris BioPharma‘s full profile, request access.

Request a free trial

Enteris BioPharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 20-Aug-2019 0000 000 Pharmaceuticals
To view Enteris BioPharma’s complete investments history, request access »

Enteris BioPharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000000000 20-Aug-2019 0000 000 Completed
  • 0000000 000000000
To view Enteris BioPharma’s complete exits history, request access »